MGI Tech Shakes Up SLAS 2026 with Groundbreaking Lab Automation and Proteomics Solutions
The landscape of life science research is shifting rapidly, and MGI Tech Co Ltd is positioning itself at the forefront of this transformation. At the Society for Laboratory Automation and Screening (SLAS) 2026 event in Vienna, Austria, the company pulled back the curtain on its latest suite of laboratory automation and integrated workflow solutions. These aren't just incremental updates; they represent a concerted effort to streamline the complex world of proteomics and clinical lab operations, making high-level research more accessible and efficient than ever before.
During the event, a spokesperson for MGI Tech highlighted the critical role of these innovations in modern science. They noted that SLAS serves as an ideal stage to showcase how intelligent automation is fundamentally changing the way laboratories function. By addressing the bottlenecks in workflow complexity and scalability, MGI Tech aims to accelerate discoveries in high-stakes fields like single-cell proteomics and organoid biology—areas where manual processes often fall short of the required precision and speed.
PrepALL-pP8G: Redefining Single-Cell Proteomics
One of the standout reveals was the PrepALL-pP8G, an ambitious extension of MGI Tech’s PrepALL platform. Specifically designed for single-cell proteomics sample pretreatment, this system tackles one of the most delicate tasks in the lab. It utilizes advanced thermal inkjet printing and high-precision, ultra-low volume dispensing to automate the entire journey from initial cell sorting to final sample preparation.
What makes the PrepALL-pP8G particularly impressive is its hardware. The system features 640 independent parallel nozzles and is supported by AI-assisted camera vision to manage 384-well plates with incredible accuracy. This level of automation is designed to safeguard cell viability and ensure protein integrity—critical factors that can make or break a proteomics study. Whether a lab is running label-free, labeled, or conventional workflows, this system is built to handle it. European researchers won't have to wait long, as the official launch in the region is slated for the second half of 2026.
GenSIRO48: The 'Sample In, Report Out' Revolution
Making its international debut, the GenSIRO48 is MGI Tech’s answer to the demand for seamless, hands-off sample processing. The philosophy behind this system is simple but powerful: "Sample In, Report Out." By integrating a massive range of steps—including nucleic acid purification, fragmentation, end repair, adapter ligation, PCR amplification, and library quality control—into a single automated path, it removes the need for constant human intervention.
Capable of processing 48 samples in parallel, the GenSIRO48 transitions laboratories from tedious manual labor to unattended execution. This is a game-changer for clinical molecular diagnosis, public health prevention, and general life science research. It allows technicians to focus on data analysis and high-level decision-making rather than the repetitive mechanics of library preparation.
Your brand deserves a better website.
We don't just use templates. We build custom web apps, landing pages, and company profiles designed specifically for what you need.
VisiOmics: Bringing Spatial Biology into Focus
Rounding out the presentation was VisiOmics, an automated staining and imaging system making its first appearance in Europe. This platform leverages multiplex immune fluorescence technology to provide a detailed look at spatial protein expression within tissue sections. In an era where the "where" of protein expression is just as important as the "what," VisiOmics provides the spatial context that researchers desperately need.
The system doesn't just stop at capturing images; it is fully integrated with an AI-powered analysis platform. This software handles the heavy lifting of cell segmentation, phenotyping, and spatial mapping. MGI Tech sees this as a vital tool for tumor classification, prognosis, and translational research, offering a streamlined workflow that connects raw tissue samples to actionable insights. Like the PrepALL-pP8G, VisiOmics is expected to be available in Europe in the latter half of 2026.
Through these releases, MGI Tech is sending a clear message: the future of the laboratory is automated, intelligent, and incredibly precise. By removing the manual hurdles in proteomics and genomics, they are paving the way for the next generation of medical and scientific breakthroughs.